HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,249.00
+5.00 (0.40%)
At close: Aug 27, 2025

HLB bioStep Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
66,02958,16952,81486,27764,40358,520
Upgrade
Other Revenue
----0-
Upgrade
66,02958,16952,81486,27764,40358,520
Upgrade
Revenue Growth (YoY)
34.30%10.14%-38.78%33.96%10.05%27.11%
Upgrade
Cost of Revenue
18,43917,33917,53332,34323,14715,819
Upgrade
Gross Profit
47,58940,83035,28153,93441,25642,701
Upgrade
Selling, General & Admin
53,53346,40731,62340,98626,52729,515
Upgrade
Research & Development
984.31824.35811.99978.141,1651,085
Upgrade
Other Operating Expenses
1,018858.76712.99709.09696.32500.65
Upgrade
Operating Expenses
61,77753,87736,46748,62532,24935,662
Upgrade
Operating Income
-14,188-13,048-1,1865,3099,0077,040
Upgrade
Interest Expense
-1,151-858.96-3,471-4,246-184.7-202.22
Upgrade
Interest & Investment Income
1,2891,8211,4691,40185205.4
Upgrade
Earnings From Equity Investments
1.681.68-488.74-1,6593,608-56.87
Upgrade
Currency Exchange Gain (Loss)
-2.864.1632.313.819.9-6.45
Upgrade
Other Non Operating Income (Expenses)
231.04233.81561.71-2,767775.48235.87
Upgrade
EBT Excluding Unusual Items
-13,820-11,845-3,083-1,94713,3007,215
Upgrade
Gain (Loss) on Sale of Investments
1,089182.733,418534.22-440.562,259
Upgrade
Gain (Loss) on Sale of Assets
258.58135.08-9.47-23.37-33.11-3.31
Upgrade
Asset Writedown
----907.99--
Upgrade
Pretax Income
-12,473-11,528325.66-2,34512,8279,471
Upgrade
Income Tax Expense
-1,761-1,835379.9-1,4621,295881.82
Upgrade
Earnings From Continuing Operations
-10,712-9,693-54.24-882.7311,5328,589
Upgrade
Net Income to Company
-10,712-9,693-54.24-882.7311,5328,589
Upgrade
Minority Interest in Earnings
1,4681,128-109.81-125.27-501.4-287.6
Upgrade
Net Income
-9,243-8,564-164.04-1,00811,0318,302
Upgrade
Net Income to Common
-9,243-8,564-164.04-1,00811,0318,302
Upgrade
Net Income Growth
----32.87%97.88%
Upgrade
Shares Outstanding (Basic)
908677706867
Upgrade
Shares Outstanding (Diluted)
908677707069
Upgrade
Shares Change (YoY)
17.05%11.80%9.59%0.02%1.35%13.51%
Upgrade
EPS (Basic)
-103.17-99.86-2.14-14.40161.87123.76
Upgrade
EPS (Diluted)
-103.30-100.00-2.14-14.40158.00120.22
Upgrade
EPS Growth
----31.42%74.23%
Upgrade
Free Cash Flow
-15,037-20,5941,1891,587-11,1357,517
Upgrade
Free Cash Flow Per Share
-167.83-240.1215.5122.67-159.09108.85
Upgrade
Gross Margin
72.07%70.19%66.80%62.51%64.06%72.97%
Upgrade
Operating Margin
-21.49%-22.43%-2.25%6.15%13.98%12.03%
Upgrade
Profit Margin
-14.00%-14.72%-0.31%-1.17%17.13%14.19%
Upgrade
Free Cash Flow Margin
-22.77%-35.40%2.25%1.84%-17.29%12.85%
Upgrade
EBITDA
-9,300-8,3452,2909,41212,0339,095
Upgrade
EBITDA Margin
-14.09%-14.35%4.33%10.91%18.68%15.54%
Upgrade
D&A For EBITDA
4,8874,7033,4764,1033,0262,056
Upgrade
EBIT
-14,188-13,048-1,1865,3099,0077,040
Upgrade
EBIT Margin
-21.49%-22.43%-2.25%6.15%13.98%12.03%
Upgrade
Effective Tax Rate
--116.66%-10.09%9.31%
Upgrade
Advertising Expenses
-178.58152.13340.63256.01126.79
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.